Study of Stimulants in EgyptSDUNCT06646822
Prevalence, Awareness, Attitudes and Patterns of Stimulant Drug Use Among Students in Egyptian Universities
An observational study of Study of Stimulants in Egypt, run by Asmaa Ahmed Hamed Mohie Eldin at 1 site in Egypt.
Trial summary
Stimulants are dangerous drugs that are commonly abused by individuals looking to stay alert and focused, lose weight, stay awake, and get high. Although these drugs can be extremely harmful and even life-threatening, many of them can also be used to treat conditions like ADHD, narcolepsy, and in some cases… Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Study of Stimulants in Egypt
- What is being tested?
- questionnaire
- How many people
- 1,500 participants
- Where
- 1 siteEgypt
- Study dates
- 10 Dec 2024to 30 Nov 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed.
Who may be able to join
- Academic student Age (18-30) years Included in medical faculty
Who cannot join
- Not undergraduates student Aged < 18 years
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Prevalence, Patterns, Awareness and Attitudes of Stimulant Drug Use Among Students in Egyptian Universities: a Cross-sectional Study.
Stimulants are dangerous drugs that are commonly abused by individuals looking to stay alert and focused, lose weight, stay awake, and get high. Although these drugs can be extremely harmful and even life-threatening, many of them can also be used to treat conditions like ADHD, narcolepsy, and in some cases, depression. There are many types of stimulant drugs, and it can be beneficial to know a little about each one, its purposes, and how harmful it can be when abused.
Illicit stimulants are usually schedule II, depending on whether or not they can be used to treat medical conditions. While some variations of stimulants are schedule I drugs, most are extremely addictive and dangerous schedule II substances. These drugs are often abused in a binge-crash pattern. According to the NIDA Teen, "In order to keep the 'high' going, people may take the drug repeatedly within a short period of time, at increasingly higher doses." This makes these drugs extremely addictive.
The aim of this survey to detect prevalence of non prescription stimulants in Egyptian students and increase their awareness of the harmful effects of these drugs.
Read the detailed description
Methodology Undergraduate students at a large public university in Egypt (Minia, Assuit, Souhag, South Valley) who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy.
Students will receive survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed. Participants will automatically routed through each section of the survey. First, students read a description of the study, including potential benefits and costs of taking the survey, and then they will be asked if they are a current undergraduate student at the participating university and their age. First section included the demographic data of participants, the second section the investigator will aske participants to indicate if they had ever been prescribed a stimulant. If participant answered yes, participants will route to the next section which asks about the frequency of use, the effects of stimulants and any complain if present.
- Conditions
- Study of Stimulants in Egypt
- Being tested
- questionnaire
- Keywords
- Prevalence, awareness, attitudes, Stimulant drug, Egyptian universities
- Medical subject headings
- Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaireOther
observational study
| Study group | Role | What they receive |
|---|---|---|
| study group | Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy.
Students were received survey through email. Students took the survey online at a time and location of their choice. Receives: Other: questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence/ pattern
- - Do/ did you use stimulants ( Recreational drugs): Yes No
- How do / did you obtain this medication Prescribed Non prescribed
- When did you start receiving stimulants for last 1 year for last 3 years for last 5 years
- Which Stimulant (drug) is/ was used
- tobacco products (e.g., coffee, chocolate, cigarettes) high caffeine products
- pseudoephedrine, ( nasal decongestant)
- methylphenidate [Ritalin]
- amphetamine [Adderall]
- methamphetamine
- modafinil (Provigil)
- dextroamphetamine (Dexedrine)
- dextro/levoamphetamine (Adderall)
- adrafinil (Olmifon)
- piracetam
- Others
Measured: 1 year
Awareness/ attitude
- How do you know about the effect of stimulants: Substance use by peers Friends as a source of prescription stimulants Social media Promotion
- Why do you use stimulant Because it helps me concentrate Because it helps me study and enhance memory Because it helps increase my alertness and concentration Because it gives me a high mood Because it helps me to be more energetic Because it improves sleep quality Because it decreases stress level Because of experimentation Because it helps me lose weight
- Do you know that stimulant is harmful to the body systems Yes No
- Which of the following side effects do you experience after using stimulant
- decreased appetite
- weight loss
- headache
- insomnia
- dizziness
- nervousness.
- Seizures
- cardiac events (increase blood pressure and heart rate, heart attacks)
- psychosis
- Did you receive treatment for the side effects after using stimulants Yes No
Measured: 1 year
Secondary outcomes (1)
Demographic data
- Age: 18-20 20-22 22-25
- Sex: Male Female
- Residence: Rural Urban
- University Minia Assiut South Valley Suhag
- Faculty Pharmacy Medicine
- Academic Year:
First tear second year Third year fourth year Fifth year
- Cigarette smoking Yes No
- Associated disorder: psychic (e.g. ADHD)
- income or economic level Low income moderate income high income
- visits to emergency department or hospital (times/ year) 1-3 4-10 11-15 >15
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Oct 2024
- Study start10 Dec 2024
- Primary completion30 Apr 2025
- Study completion30 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Study of Stimulants in EgyptStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Asmaa Ahmed Hamed Mohie Eldin
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Asmaa Ahmed Hamed Mohie Eldin, New Valley University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06646822
- Sponsor's protocol ID
- MPEC 240704
- Other IDs
- MPEC 240704
- Acronym
- SDU
- Status last verified
- Oct 2024
- First submitted
- 9 Oct 2024
- Last updated
- 2 Oct 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence, Patterns, Awareness and Attitudes of Stimulant Drug Use Among Students in Egyptian Universities: a Cross-sectional Study.
- ClinicalTrials.gov ID
- NCT06646822
- Acronym / sponsor ID
- SDU / MPEC 240704
- Conditions
- Study of Stimulants in Egypt
- Keywords
- Prevalence, awareness, attitudes, Stimulant drug, Egyptian universities
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,500 participants (estimated)
- Lead sponsor
- Asmaa Ahmed Hamed Mohie EldinUniversity, hospital or other
- Study start
- 10 Dec 2024 (actual)
- Primary completion
- 30 Apr 2025 (actual)
- Study completion
- 30 Nov 2025 (estimated)
- First posted
- 17 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Stimulants are dangerous drugs that are commonly abused by individuals looking to stay alert and focused, lose weight, stay awake, and get high. Although these drugs can be extremely harmful and even life-threatening, many of them can also be used to treat conditions like ADHD, narcolepsy, and in some cases, depression. There are many types of stimulant drugs, and it can be beneficial to know a little about each one, its purposes, and how harmful it can be when abused.
Illicit stimulants are usually schedule II, depending on whether or not they can be used to treat medical conditions. While some variations of stimulants are schedule I drugs, most are extremely addictive and dangerous schedule II substances. These drugs are often abused in a binge-crash pattern. According to the NIDA Teen, "In order to keep the 'high' going, people may take the drug repeatedly within a short period of time, at increasingly higher doses." This makes these drugs extremely addictive.
The aim of this survey to detect prevalence of non prescription stimulants in Egyptian students and increase their awareness of the harmful effects of these drugs.
Detailed description
Methodology Undergraduate students at a large public university in Egypt (Minia, Assuit, Souhag, South Valley) who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy.
Students will receive survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed. Participants will automatically routed through each section of the survey. First, students read a description of the study, including potential benefits and costs of taking the survey, and then they will be asked if they are a current undergraduate student at the participating university and their age. First section included the demographic data of participants, the second section the investigator will aske participants to indicate if they had ever been prescribed a stimulant. If participant answered yes, participants will route to the next section which asks about the frequency of use, the effects of stimulants and any complain if present.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| study group | – | Other: questionnaireUndergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed.
Key inclusion criteria (1 listed)
- Academic student Age (18-30) years Included in medical faculty
Key exclusion criteria (1 listed)
- Not undergraduates student Aged < 18 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnaireobservational study | Other | study group |
Primary outcome
Prevalence/ pattern
Time frame: 1 year
* - Do/ did you use stimulants ( Recreational drugs): Yes No * How do / did you obtain this medication Prescribed Non prescribed * When did you start receiving stimulants for last 1 year for last 3 years for last 5 years * Which Stimulant (drug) is/ was used * tobacco products (e.g., coffee, chocolate, cigarettes) high caffeine products * pseudoephedrine, ( nasal decongestant) * methylphenidate [Ritalin] * amphetamine [Adderall] * methamphetamine * modafinil (Provigil) * dextroamphetamine (Dexedrine) * dextro/levoamphetamine (Adderall) * adrafinil (Olmifon) * piracetam * Others
Awareness/ attitude
Time frame: 1 year
- How do you know about the effect of stimulants: Substance use by peers Friends as a source of prescription stimulants Social media Promotion * Why do you use stimulant Because it helps me concentrate Because it helps me study and enhance memory Because it helps increase my alertness and concentration Because it gives me a high mood Because it helps me to be more energetic Because it improves sleep quality Because it decreases stress level Because of experimentation Because it helps me lose weight * Do you know that stimulant is harmful to the body systems Yes No * Which of the following side effects do you experience after using stimulant * decreased appetite * weight loss * headache * insomnia * dizziness * nervousness. * Seizures * cardiac events (increase blood pressure and heart rate, heart attacks) * psychosis * Did you receive treatment for the side effects after using stimulants Yes No
1 secondary outcome
Demographic data
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Study of Stimulants in Egypt, run by Asmaa Ahmed Hamed Mohie Eldin at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 2 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence/ pattern (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2025.